ZYME logo

Zymeworks (ZYME) Company Overview

Profile

Full Name:

Zymeworks Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 28, 2017

Indexes:

Not included

Description:

Zymeworks is a biotechnology company that develops innovative therapies for cancer and other diseases. They focus on creating protein-based treatments using their advanced technology platform, which helps design and optimize new drugs to improve patient outcomes and enhance the effectiveness of existing therapies.

Key Details

Price

$12.93

Annual Revenue

$76.01 M(-81.57% YoY)

Annual EPS

-$1.72(-190.53% YoY)

Annual ROE

-24.78%

Beta

1.01

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 5, 2025

Recent annual earnings:

Mar 5, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 19, 24 Wells Fargo
Equal-Weight
Dec 16, 24 JP Morgan
Overweight
Nov 22, 24 HC Wainwright & Co.
Neutral
Nov 7, 24 Leerink Partners
Outperform
Nov 4, 24 Citigroup
Buy
Nov 1, 24 Wells Fargo
Equal-Weight
Nov 1, 24 HC Wainwright & Co.
Neutral
Oct 28, 24 Stifel
Buy
Aug 2, 24 Stifel
Buy
Jun 6, 24 HC Wainwright & Co.
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Zymeworks?
  • Does Zymeworks pay dividends?
  • What sector is Zymeworks in?
  • What industry is Zymeworks in?
  • What country is Zymeworks based in?
  • When did Zymeworks go public?
  • Is Zymeworks in the S&P 500?
  • Is Zymeworks in the NASDAQ 100?
  • Is Zymeworks in the Dow Jones?
  • When was Zymeworks's last earnings report?
  • When does Zymeworks report earnings?
  • Should I buy Zymeworks stock now?

What is the ticker symbol for Zymeworks?

The ticker symbol for Zymeworks is NYSE:ZYME

Does Zymeworks pay dividends?

No, Zymeworks does not pay dividends

What sector is Zymeworks in?

Zymeworks is in the Healthcare sector

What industry is Zymeworks in?

Zymeworks is in the Biotechnology industry

What country is Zymeworks based in?

Zymeworks is headquartered in United States

When did Zymeworks go public?

Zymeworks's initial public offering (IPO) was on April 28, 2017

Is Zymeworks in the S&P 500?

No, Zymeworks is not included in the S&P 500 index

Is Zymeworks in the NASDAQ 100?

No, Zymeworks is not included in the NASDAQ 100 index

Is Zymeworks in the Dow Jones?

No, Zymeworks is not included in the Dow Jones index

When was Zymeworks's last earnings report?

Zymeworks's most recent earnings report was on Mar 5, 2025

When does Zymeworks report earnings?

The date for Zymeworks's next earnings report has not been announced yet

Should I buy Zymeworks stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions